These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37035154)

  • 1. Application status and future prospects of the PDX model in lung cancer.
    Liu W; Cui Y; Zheng X; Yu K; Sun G
    Front Oncol; 2023; 13():1098581. PubMed ID: 37035154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine.
    Gao Y; Zhou R; Huang JF; Hu B; Cheng JW; Huang XW; Wang PX; Peng HX; Guo W; Zhou J; Fan J; Yang XR
    Front Oncol; 2021; 11():704042. PubMed ID: 34327143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.
    Zeng M; Ruan Z; Tang J; Liu M; Hu C; Fan P; Dai X
    Cancer Cell Int; 2023 Jun; 23(1):120. PubMed ID: 37344821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine.
    Morgan KM; Riedlinger GM; Rosenfeld J; Ganesan S; Pine SR
    Front Oncol; 2017; 7():2. PubMed ID: 28154808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients.
    Kim Y; Kim D; Cao B; Carvajal R; Kim M
    BMC Bioinformatics; 2020 Jul; 21(1):288. PubMed ID: 32631229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer.
    Pu X; Zhang R; Wang L; Chen Y; Xu Y; Pataer A; Meraz IM; Zhang X; Wu S; Wu L; Su D; Mao W; Heymach JV; Roth JA; Swisher SG; Fang B
    J Transl Med; 2018 Nov; 16(1):328. PubMed ID: 30477533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.
    Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL
    BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib.
    Lee AQ; Ijiri M; Rodriguez R; Gandour-Edwards R; Lee J; Tepper CG; Li Y; Beckett L; Lam K; Goodwin N; Satake N
    Front Oncol; 2021; 11():648097. PubMed ID: 33842362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived xenografts as preclinical neuroblastoma models.
    Braekeveldt N; Bexell D
    Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.
    Scott CL; Becker MA; Haluska P; Samimi G
    Front Oncol; 2013 Dec; 3():295. PubMed ID: 24363999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of stable PDX derived cell lines using conditional reprogramming.
    Borodovsky A; McQuiston TJ; Stetson D; Ahmed A; Whitston D; Zhang J; Grondine M; Lawson D; Challberg SS; Zinda M; Pollok BA; Dougherty BA; D'Cruz CM
    Mol Cancer; 2017 Dec; 16(1):177. PubMed ID: 29212548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
    Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
    J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
    Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
    J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications.
    Jung HY; Kim TH; Lee JE; Kim HK; Cho JH; Choi YS; Shin S; Lee SH; Rhee H; Lee HK; Choi HJ; Jang HY; Lee S; Kang JH; Choi YA; Lee S; Lee J; Choi Y; Kim J
    J Transl Med; 2020 Aug; 18(1):307. PubMed ID: 32762722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
    Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
    Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies.
    Gürgen D; Becker M; Dahlmann M; Flechsig S; Schaeffeler E; Büttner FA; Schmees C; Bohnert R; Bedke J; Schwab M; Wendler JJ; Schostak M; Jandrig B; Walther W; Hoffmann J
    Front Oncol; 2022; 12():889789. PubMed ID: 35800063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.